Provided by Tiger Trade Technology Pte. Ltd.

Autonomix Medical Inc

7.19
+1.8233.89%
Post-market: 7.07-0.1200-1.67%18:50 EDT
Volume:28.55M
Turnover:243.96M
Market Cap:6.98M
PE:-0.15
High:9.99
Open:7.61
Low:7.15
Close:5.37
52wk High:32.55
52wk Low:2.44
Shares:971.04K
Float Shares:954.67K
Volume Ratio:8.88
T/O Rate:2990.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-46.5038
EPS(LYR):-48.7200
ROE:-315.99%
ROA:-157.81%
PB:2.21
PE(LYR):-0.15

Loading ...

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

GlobeNewswire
·
Jun 22

Autonomix announces reverse stock split

TIPRANKS
·
Jun 19

Autonomix Medical effects 1-for-21 reverse stock split June 24

Reuters
·
Jun 19

Autonomix Announces Reverse Stock Split

THOMSON REUTERS
·
Jun 19

Autonomix CEO Hauser touts growing conference recognition for nerve-sensing platform in CEO Corner interview

Reuters
·
Jun 10

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

THOMSON REUTERS
·
Jun 10

Autonomix Medical spotlights pancreatic cancer pain feasibility data at surgical oncology meeting

Reuters
·
Jun 04

Autonomix Medical joins virtual investor “What This Means” segment on SSO annual meeting data

Reuters
·
Jun 04

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

GlobeNewswire
·
Jun 04

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

Autonomix net loss widens to $16.7 million in FY26; operating expenses rise 47% to $17.03 million

Reuters
·
May 28

Autonomix granted U.S. patent for transvascular monitoring, treatment systems

TIPRANKS
·
May 19

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems With Real-Time Procedural Validation

THOMSON REUTERS
·
May 19

Autonomix Medical wins US patent for transvascular monitoring, real-time procedural validation system

Reuters
·
May 19

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

GlobeNewswire
·
May 19

Autonomix Medical attends EuroPCR with abstracts on pancreatic cancer pain mitigation

Reuters
·
May 18

Autonomix Medical Announces Abstract Acceptances at Europcr 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

THOMSON REUTERS
·
May 18

BRIEF-Autonomix Medical Announces Abstract Acceptance At Digestive Disease Week 2026

Reuters
·
Apr 29

Autonomix long-term pancreatic cancer pain data accepted for presentation at DDW 2026

Reuters
·
Apr 29

Autonomix Medical to present long-term pancreatic cancer pain data at ECIO 2026

Reuters
·
Apr 22